(Z,Z)-2,7-Bis(4-amidinobenzylidene)cycloheptan-1-one: identification of a highly active inhibitor of blood coagulation factor Xa. - Suppr | 超能文献

(Z,Z)-2,7-Bis(4-amidinobenzylidene)cycloheptan-1-one: identification of a highly active inhibitor of blood coagulation factor Xa.

作者信息

Shaw K J, Guilford W J, Dallas J L, Koovakkaat S K, McCarrick M A, Liang A, Light D R, Morrissey M M

机构信息

Discovery Research, Berlex Biosciences, 15049 San Pablo Avenue, P.O. Box 4099, Richmond, California 94804-0099, USA.

出版信息

J Med Chem. 1998 Sep 10;41(19):3551-6. doi: 10.1021/jm980281+.

DOI:10.1021/jm980281+

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

(Z,Z)-2,7-Bis(4-amidinobenzylidene)cycloheptan-1-one: identification of a highly active inhibitor of blood coagulation factor Xa.

J Med Chem. 1998 Sep 10;41(19):3551-6. doi: 10.1021/jm980281+.

2

Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa.N-[2-[5-[氨基（亚氨基）甲基]-2-羟基苯氧基]-3,5-二氟-6-[3-(4,5-二氢-1-甲基-1H-咪唑-2-基)苯氧基]吡啶-4-基]-N-甲基甘氨酸（ZK-807834）的发现：一种强效、选择性且口服活性的凝血酶因子Xa抑制剂。

J Med Chem. 1998 Sep 10;41(19):3557-62. doi: 10.1021/jm980280h.

3

Design, synthesis, and activity of 2,6-diphenoxypyridine-derived factor Xa inhibitors.2,6 - 二苯氧基吡啶衍生的凝血因子Xa抑制剂的设计、合成及活性

J Med Chem. 1999 May 20;42(10):1749-56. doi: 10.1021/jm980667k.

4

Identification and initial structure-activity relationships of a novel class of nonpeptide inhibitors of blood coagulation factor Xa.新型凝血因子Xa非肽类抑制剂的鉴定及初步构效关系研究

J Med Chem. 1998 Feb 12;41(4):437-50. doi: 10.1021/jm970482y.

5

Rational design and synthesis of novel, potent bis-phenylamidine carboxylate factor Xa inhibitors.新型强效双苯基脒羧酸酯因子Xa抑制剂的合理设计与合成

J Med Chem. 1998 Jan 1;41(1):53-62. doi: 10.1021/jm970485a.

6

A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin.一种新型凝血因子Xa抑制剂：结构-活性关系以及凝血因子Xa与凝血酶之间的选择性

Biochem Biophys Res Commun. 1993 Dec 15;197(2):965-72. doi: 10.1006/bbrc.1993.2573.

7

Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.基于机制的高选择性凝血酶抑制剂：用刚性肽醛抑制的凝血酶和胰蛋白酶的结构

Biochemistry. 1998 Sep 1;37(35):12094-103. doi: 10.1021/bi980840e.

8

Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.作为凝血因子Xa抑制剂的尿烷-3-脒基苯丙氨酸衍生物。胰蛋白酶/抑制剂复合物的X射线晶体结构及建模研究。

Biol Chem. 2000 Apr;381(4):321-9. doi: 10.1515/BC.2000.042.

9

Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.与胰蛋白酶复合的基于苯甲脒的抑制剂的结构和功能分析：对因子Xa、组织型纤溶酶原激活剂和尿激酶抑制作用的启示

J Med Chem. 1998 Dec 31;41(27):5445-56. doi: 10.1021/jm981068g.

10

Incorporation of neutral C-terminal residues in 3-amidinophenylalanine-derived matriptase inhibitors.3-脒基苯丙氨酸衍生的胃蛋白酶解激活素抑制剂中中性C末端残基的掺入。

Bioorg Med Chem Lett. 2009 Apr 1;19(7):1960-5. doi: 10.1016/j.bmcl.2009.02.047. Epub 2009 Feb 14.

引用本文的文献

1

Factor Xa: simulation studies with an eye to inhibitor design.凝血因子Xa：着眼于抑制剂设计的模拟研究

J Comput Aided Mol Des. 2000 Aug;14(6):507-29. doi: 10.1023/a:1008120005475.